Neuromuscular conferences to take place in Canada in 2023

In 2023, several neuromuscular conferences will take place in Canada, hosted by both Canadian and international organizations. These in-person conferences will provide training opportunities, clinical and research updates, and networking opportunities for neuromuscular clinicians and researchers from around the world.

The Canadian Neurological Sciences Federation Congress, the Annual NMD4C Meeting, the Ottawa International Conference on Neuromuscular Disease and Biology, and the World Federation of Neurology’s World Congress of Neurology will all be held in Canada this year.

You can find more information on these events, and other international neuromuscular conferences under the events section of our website.

2023 CNSF congress will take place from June 6th-9th 2023 in Banff, Alberta

Canadian Neurological Sciences Federation (CNSF) Congress 2023

Date: June 6 – 9, 2023

Location: Banff, Alberta

Deadlines: Early bird registration: May 4th, 2023

This annual Canadian Congress with four days of accredited scientific courses to assist CNSF members, and others community members with learning and CME opportunities across a variety of neuroscience disciplines.

 

Neuromuscular-specific sessions at the congress include:

  • Jun 6, 8-10:30am | Advances in treatments of hereditary neuromuscular diseases in children and adults
  • Jun 6, 5:15-6:45pm | CCS: Neuromuscular Case Discussion
  • Jun 7, 8-9:30am Grand Plenary CSCN Gloor Lecture: presented by NMD4C investigator Dr Jodi Warman Chardon
  • Jun 8, 12-1:30pm | Lunch ‘n Learn: Measuring outcomes that matter to patients in neuromuscular disease: An individualized approach to transitioning from IVIg to home based therapy with SCIg

Registration is now open, and the congress program is also available.

 

Registration open for NMD4C annual meeting taking place September 7, 2023

Annual NMD4C Meeting

Date: September 7th, 2023 (one day before the Ottawa International Conference on Neuromuscular Disease and Biology)

Location: Ottawa, Ontario

This one-day in-person meeting is an opportunity for our network investigators, researchers, clinicians, trainees, and patient partners to foster collaboration, showcase our progress, discuss emerging topics, and set our priorities going forward.

Registration for our annual meeting is now open, and we encourage our members to attend!

 

Ottawa NMD conference poster6th Ottawa International Conference on Neuromuscular Disease and Biology

Date: September 7-9, 2023

Location: Ottawa, Ontario

Deadlines: Abstract Submission Deadline: June 30th, 2023

 

 

The Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023) will feature top international basic and clinical neuromuscular researchers highlighting advances in neuromuscular disease research and clinical care, including novel diagnostic techniques, disease pathogenesis, basic muscle and stem cell biology, and promising therapies to treat these devastating disorders. Sessions will be organized to include basic, translational and clinical presentations to engage all attendees, regardless of background or training.

Registration is now open, and  the full program is also available.

 

World Federation of Neurology congress to take place in Montreal in October 2023World Federation of Neurology’s 26th World Congress of Neurology (WCN 2023)

Date: October 15-19, 2023

Location: Montreal, Quebec

Deadlines: Abstract submission: April 5th, 2023

The WCN 2023 is hosted by the World Federation of Neurology and co-hosted by the Canadian Neurological Sciences Federation (CNSF) for 2023. WCN 2023 provides updates in the broad field of neurology, from tropical neurology to molecular genetics.

 

Neuromuscular-specific sessions at the congress include:

  • Oct 15, 9:15-10:45 am | EMG workshop 1
  • Oct 15, 11:15am-12:45pm | EMG workshop 2
  • Oct 17, 9-10:30am | Neuromuscular Diseases: WFN, PNS & ICNMD Joint Session: Update On Inflammatory Conditions Of The Peripheral And Central Nervous System (scientific session)
  • Oct 17, 9-10:30am | Peripheral neuropathies (teaching course)
  • Oct 17, 11am-12:30pm | Neuromuscular diseases: WFN, PNS & ICNMD joint session: Advances in management of acquired and hereditary neuromuscular disorders (scientific session)
  • Oct 17, 11am-12:30pm | Neurogenetics (teaching course)
  • Oct 17, 11am-12:30pm | Ataxia (scientific session)
  • Oct 17, 2:45-4:15pm | Spinal muscular atrophy: from genotype to phenotype and therapy (scientific session)
  • Oct 17, 2:45-4:15pm | Update on acquired and hereditary demyelinating neuropathies (scientific session)
  • Oct 18, 7- 8:00am | Is it a myopathy? (teaching course)
  • Oct 18, 9-10:30am | Neuromuscular disorders part 1 (teaching course)
  • Oct 18, 11am-12:30pm | Neuromuscular disorders part 2 (teaching course)
  • Oct 19, 9-10:30am | Neuromuscular disease: myasthenia gravis & inflammatory myopathies (scientific session)
  • Oct 19, 11-12:30pm | Genetic therapies for hereditary neuromuscular diseases (scientific session)

Registration is now open, and the full scientific program is also available.

Upcoming neuromuscular conferences

Read next...

2024 NMD4C basic research summer school. Photo of attendees on the right.

NMD4C Host Inaugural Basic Research Summer School

Over May 27-28 2024, the NMD4C animal and cell-based research team hosted the first-ever annual basic research summer school for neuromuscular research trainees at McGill University in Montréal, QC. 

NMD4C investigator Dr Reshma Amin receives funding from CIHR for a grant to develop a framework for real-world evidence for NMDs in Canada

NMD4C Investigator Dr. Reshma Amin Leads Successful CIHR Grant Application to Establish a Framework for Real-World Evidence for Canadian Neuromuscular Diseases

Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs   The NMD4C is excited to share that network investigator Dr. Reshma Amin has been awarded funding from the CIHR to establish a framework for real-world evidence (RWE) for Canadian…

Spinal muscular atrophy outcome measures training registration open for December 3rd event.

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

The NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures. 

Canadian Neuromuscular Community of Practice

NMD4C Launch Survey to Assess Familiarity and Experience in Outcome Measures in NMDs

As we anticipate novel treatments for other neuromuscular conditions, we would like to understand your familiarity and experience with the outcome measures in clinical trials underway or for treatments for NMDs approved in other jurisdictions through a short survey.

IDMC-14_steinertaward_Cynthia_4x3

Dr. Cynthia Gagnon Receives 2024 Steinert Award, IDMC-15 Meeting to Take Place in Saguenay 

We are pleased to share that NMD4C steering committee member Dr. Cynthia Gagnon was honoured with a Steinert Award at the recent International Myotonic Dystrophy Consortium Meeting (IDMC-14) in Nijmegen, Netherlands! 

2024 Dr David Green Award winners from MDC

NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.